# Pregabalin

## Lyrica 75mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OLYR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Indications        | Diabetic peripheral neuropathy - neuropathic pain， fibromyalgia， neuropathic pain - spinal cord injury， partial seizure – adjunct， postherpetic neuralgia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Diabetic peripheral neuropathy - neuropathic pain: initial， 75 mg two times a day (150 mg/day) and may be increased to 150 mg two times a day (maximum 300 mg/day). Fibromyalgia: initial， 75 mg twice a day (150 mg/day)， may increase to 150 mg twice a day (300 mg/day) within 1 week and to 225 mg twice a day (maximum 450 mg/day). Neuropathic pain - spinal cord injury: initial， 75 mg two times a day; may increase to 150 mg two times a day within 1 week; may further increase to 300 mg two times a day for insufficient pain relief after 2 to 3 weeks of treatment. Partial seizure - adjunct: initial， no greater than 75 mg two times a day or 50 mg three times a day (150 mg/day) and increased to a maximum dose of 600 mg/day in divided doses (either two or three times a day) based on response and tolerability. Postherpetic neuralgia: initial， 75 mg two times a day or 50 mg three times a day; maintenance， 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day)， in patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and are tolerating pregabalin， may increase dosage up to 300 mg two times a day， or 200 mg three times a day (600 mg/day). Safety and efficacy have not been established in pediatric patients. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity to pregabalin or any other component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | (Common) Cardiovascular: Peripheral edema (5% to 12% ) Endocrine metabolic: Increased appetite (5% )， Weight gain (3.3% to 12% ) Gastrointestinal: Constipation (4% to 8.2% )， Xerostomia (2.3% to 11% ) Neurologic: Asthenia (5% to 10% )， Ataxia (3% to 15% )， Dizziness (9.1% to 42.7% )， Headache (5.6% to 9.3% )， Incoordination (2% to 10.1% )， Somnolence (10.2% to 35.7% )， Tremor (1% to 11.2% ) Ophthalmic: Blurred vision (3.4% to 10.1% )， Diplopia (2% to 9% ) Psychiatric: Disturbance in thinking (2% to 8% )， Euphoria (2% to 6% ) Respiratory: Nasopharyngitis (8.2% ) Other: Fatigue (7% to 11% ) (Serious) Hepatic: Jaundice Immunologic: Hypersensitivity reaction Musculoskeletal: Increased creatine kinase level (1.5% to 2.7% ) Psychiatric: Suicidal thoughts Other: Angioedema                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Pregnancy          | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

